APPN vs PAYO

Appian Corporation exhibits strong deterministic health with a Piotroski F-Score of 7/9, indicating solid operational efficiency and financial stability despite lacking an Altman Z-Score for bankruptcy risk assessment. The company demonstrates robust revenue growth at 21.7% YoY and a high gross margin of 72.54%, underpinned by consistent earnings surprises averaging 228% over the last four quarters. However, the stock trades at an extremely high forward P/E of 21.99 and a negative Price/Book of -40.30, reflecting deep market skepticism about current profitability and asset value. While insider sentiment is bearish due to a recent sale, analyst target prices suggest upside potential, though consensus remains weak. The intrinsic value estimate of $0.14 is vastly below current price, signaling a significant premium driven by growth expectations.

PAYO presents a conflict between deterministic value and analyst sentiment, with a Piotroski F-Score of 4/9 indicating stable but mediocre financial health. The stock trades at a significant premium to its Graham Number ($2.94) and Intrinsic Value ($2.75), suggesting the market is pricing in future growth not yet fully realized in the trailing data. While the balance sheet is exceptionally clean with very low debt, the slow YoY revenue growth (4.9%) contrasts with a strong 'Strong Buy' analyst consensus and a target price of $7.50. Recent short-term price momentum is positive, but long-term performance remains deeply bearish.